Bucumolol

Bucumolol
Names
IUPAC name
8-[3-(tert-Butylamino)-2-hydroxypropoxy]-5-methylchromen-2-one
Identifiers
CAS Number
  • 58409-59-9
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL349807
ChemSpider
  • 148482
KEGG
  • D01492
MeSH C024221
PubChem CID
  • 169787
UNII
  • U8WVJ3501L
InChI
  • InChI=1S/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYSA-N
  • InChI=1/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYAD
  • CC1=C2C=CC(=O)OC2=C(C=C1)OCC(CNC(C)(C)C)O
Properties
Chemical formula
C17H23NO4
Molar mass 305.374 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Chemical compound

Bucumolol is a beta-adrenergic antagonist.[1]

References

  1. ^ Nakayama, K; Oshima, T; Koike, H (1981). "Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs". Archives Internationales de Pharmacodynamie et de Thérapie. 254 (1): 145–56. PMID 6121536.


  • v
  • t
  • e
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e